======= AGAP2 =======
== Gene Information ==
* **Official Symbol**: AGAP2
* **Official Name**: ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=116986|116986]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q99490|Q99490]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=AGAP2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGAP2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605476|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: The protein encoded by this gene belongs to the centaurin gamma-like family. It mediates anti-apoptotic effects of nerve growth factor by activating nuclear phosphoinositide 3-kinase. It is overexpressed in cancer cells, and promotes cancer cell invasion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: GTPase-activating protein (GAP) for ARF1 and ARF5, which also shows strong GTPase activity. Isoform 1 participates in the prevention of neuronal apoptosis by enhancing PI3 kinase activity. It aids the coupling of metabotropic glutamate receptor 1 (GRM1) to cytoplasmic PI3 kinase by interacting with Homer scaffolding proteins, and also seems to mediate anti-apoptotic effects of NGF by activating nuclear PI3 kinase. Isoform 2 does not stimulate PI3 kinase but may protect cells from apoptosis by stimulating Akt. It also regulates the adapter protein 1 (AP-1)-dependent trafficking of proteins in the endosomal system. It seems to be oncogenic. It is overexpressed in cancer cells, prevents apoptosis and promotes cancer cell invasion. {ECO:0000269|PubMed:12640130, ECO:0000269|PubMed:14761976, ECO:0000269|PubMed:15118108, ECO:0000269|PubMed:16079295}.
|ArfGap|
|Miro|
|Ank 2|
|PH|
|Ras|
|regulation of 1-phosphatidylinositol-3-kinase activity|
|positive regulation of 1-phosphatidylinositol-3-kinase activity|
|positive regulation of phosphatidylinositol biosynthetic process|
|regulation of phosphatidylinositol biosynthetic process|
|positive regulation of phospholipid biosynthetic process|
|regulation of phospholipid biosynthetic process|
|positive regulation of phosphatidylinositol 3-kinase activity|
|positive regulation of lipid kinase activity|
|positive regulation of phospholipid metabolic process|
|regulation of phosphatidylinositol 3-kinase activity|
|regulation of lipid kinase activity|
|positive regulation of lipid biosynthetic process|
|regulation of phospholipid metabolic process|
|negative regulation of protein catabolic process|
|positive regulation of lipid metabolic process|
|negative regulation of neuron apoptotic process|
|regulation of lipid biosynthetic process|
|negative regulation of neuron death|
|regulation of neuron apoptotic process|
|GTPase activator activity|
|negative regulation of catabolic process|
|regulation of neuron death|
|GTPase activity|
|regulation of protein catabolic process|
|GTP binding|
|regulation of lipid metabolic process|
|positive regulation of GTPase activity|
|regulation of GTPase activity|
|positive regulation of kinase activity|
|positive regulation of transferase activity|
|positive regulation of hydrolase activity|
|nucleolus|
|regulation of kinase activity|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|regulation of transferase activity|
|regulation of catabolic process|
|negative regulation of cell death|
|positive regulation of phosphorylation|
|negative regulation of protein metabolic process|
|positive regulation of phosphate metabolic process|
|positive regulation of phosphorus metabolic process|
|mitochondrion|
|regulation of hydrolase activity|
|positive regulation of catalytic activity|
|protein transport|
|peptide transport|
|regulation of apoptotic process|
|regulation of programmed cell death|
|amide transport|
|regulation of phosphorylation|
|establishment of protein localization|
|regulation of cell death|
|positive regulation of molecular function|
|regulation of phosphate metabolic process|
|regulation of phosphorus metabolic process|
|nitrogen compound transport|
|positive regulation of cellular biosynthetic process|
|membrane|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp331|A-769662 20μM R07 exp331]]|1.71|
|[[:results:exp319|ABT-702 5μM plus Dimethyloxaloylglycine 11μM R07 exp319]]|1.8|
|[[:results:exp340|BN82002 4μM R07 exp340]]|1.81|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 3224
* **Expression level (log2 read counts)**: 4.37
{{:chemogenomics:nalm6 dist.png?nolink |}}